| Trial ID: | L0202 |
| Source ID: | NCT01066364
|
| Associated Drug: |
Colesevelam
|
| Title: |
Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01066364/results
|
| Conditions: |
Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: Colesevelam Hcl
|
| Outcome Measures: |
The Primary Outcome Will be Improvement in Hepatic Steatosis by Liver MRI|Insulin Sensitivity as Determined by HOMA-IR|Serum ALT and AST Values|Lipid Profiles
|
| Sponsor/Collaborators: |
University of California, San Diego|Daiichi Sankyo, Inc.
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
59
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment
|
| Start Date: |
February 2010
|
| Completion Date: |
February 2012
|
| Results First Posted: |
July 21, 2020
|
| Last Update Posted: |
July 21, 2020
|
| Locations: |
UCSD: Prevention Studies Clinic, La Jolla, California, United States|UCSD: Medical Center- Hillcrest, San Diego, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01066364
|
